TY - JOUR
T1 - Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors
AU - Takaoka, Akinori
AU - Yanai, Hideyuki
AU - Kondo, Seiji
AU - Duncan, Gordon
AU - Negishi, Hideo
AU - Mizutani, Tatsuaki
AU - Kano, Shin Ichi
AU - Honda, Kenya
AU - Ohba, Yusuke
AU - Mak, Tak W.
AU - Taniguchi, Tadatsugu
N1 - Funding Information:
Acknowledgements We thank J. Vilcek, R. Flavell, H. Rosen and N. Fujiwara for advice, and M. Shishido for technical assistance. This work was supported in part by a grant for Advanced Research on Cancer and a Grant-In-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Uehara Memorial Foundation, Mitsukoshi Foundation, the Princess Takamatsu Cancer Research Fund and Canadian Institute of Health Research. H.Y. is a research fellow of the Japan Society for the Promotion of Science. H.N. and S.K. were supported by an Ishidu Shun Memorial Scholarship.
Funding Information:
Acknowledgements We thank J. D. Stone and L. Stern for providing the crosslinker reagent to initiate these studies as well as for helpful discussions. We thank B. Lillemeier for Baculovirus DNA encoding His-tagged ICAM-1 and B7-1. We thank C. Schæfer-Nielsen, M. Kuhns, A. Krogsgaard and members of the Davis and Chien laboratory for helpful discussions. We thank K. C. Garcia and M. Winslow for critical reading of the manuscript and helpful discussions and analysis. We thank N. Prado and B. Smith for technical assistance. M.K. was a postdoctoral fellow of the Alfred Benzon Foundation and the Danish Medical Research Council. Q.L. and M.H. are supported by Helen Hay Whitney Foundation Fellowships. This work is supported by grants from the NIH and from the Howard Hughes Medical Institute.
PY - 2005/3/10
Y1 - 2005/3/10
N2 - The activation of Toll-like receptors (TLRs) is central to innate and adaptive immunity1-3. All TLRs use the adaptor MyD88 for signalling4, but the mechanisms underlying the MyD88-mediated gene induction programme are as yet not fully under-stood. Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-α. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired, whereas interferon-α induction is normal. We also provide evidence that IRF-5 interacts with and is activated by MyD88 and TRAF6, and that TLR activation results in the nuclear translocation of IRF-5 to activate cytokine gene transcription. Consistently, Irf5-/- mice show resistance to lethal shock induced by either unmethylated DNA or lipopolysaccharide, which correlates with a marked decrease in the serum levels of proinflammatory cytokines. Thus, our study identifies IRF-5 as a new, principal downstream regulator of the TLR-MyD88 signalling pathway and a potential target of therapeutic intervention to control harmful immune responses.
AB - The activation of Toll-like receptors (TLRs) is central to innate and adaptive immunity1-3. All TLRs use the adaptor MyD88 for signalling4, but the mechanisms underlying the MyD88-mediated gene induction programme are as yet not fully under-stood. Here, we demonstrate that the transcription factor IRF-5 is generally involved downstream of the TLR-MyD88 signalling pathway for gene induction of proinflammatory cytokines, such as interleukin-6 (IL-6), IL-12 and tumour-necrosis factor-α. In haematopoietic cells from mice deficient in the Irf5 gene (Irf5-/- mice), the induction of these cytokines by various TLR ligands is severely impaired, whereas interferon-α induction is normal. We also provide evidence that IRF-5 interacts with and is activated by MyD88 and TRAF6, and that TLR activation results in the nuclear translocation of IRF-5 to activate cytokine gene transcription. Consistently, Irf5-/- mice show resistance to lethal shock induced by either unmethylated DNA or lipopolysaccharide, which correlates with a marked decrease in the serum levels of proinflammatory cytokines. Thus, our study identifies IRF-5 as a new, principal downstream regulator of the TLR-MyD88 signalling pathway and a potential target of therapeutic intervention to control harmful immune responses.
UR - http://www.scopus.com/inward/record.url?scp=15044345461&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=15044345461&partnerID=8YFLogxK
U2 - 10.1038/nature03308
DO - 10.1038/nature03308
M3 - Article
C2 - 15665823
AN - SCOPUS:15044345461
SN - 0028-0836
VL - 434
SP - 243
EP - 249
JO - Nature
JF - Nature
IS - 7030
ER -